Taken together, these findings clearly demonstrated that AANG preventive treatment effectively inhibits Smad3-mediated renal fibrosis and NF-κB -driven renal inflammation, thereby protecting the kidney from the development of T2DN in db/db mice. The gene discussed is SMAD3; the disease is renal fibrosis.